NCT00730782View on ClinicalTrials.gov

Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

August 31, 2008

Conditions
Plasmodium Falciparum Malaria
Interventions
BIOLOGICAL

PfAMA-1-FVO[25-545]

Subcutaneous vaccination of 0.5ml of two dosage 10 and 50ug PfAMA1

Trial Locations (2)

Unknown

Radboud University Nijmegen Medical Centre, Nijmegen

Biomedical Primate Research Centre, Rijswijk

Sponsors
All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

collaborator

Biomedical Primate Research Centre

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Seppic

INDUSTRY

lead

European Vaccine Initiative

OTHER

NCT00730782 - Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers | Biotech Hunter | Biotech Hunter